Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact

M MacLeod, A Papi, M Contoli, B Beghé, BR Celli… - …, 2021 - Wiley Online Library
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …

Inflammatory endotypes in COPD

PJ Barnes - Allergy, 2019 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is a major global health problem that is
poorly treated by current therapies as it has proved difficult to treat the underlying …

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised …

A Papi, J Vestbo, L Fabbri, M Corradi, H Prunier… - The Lancet, 2018 - thelancet.com
Background Evidence is scarce on the relative risk-benefit of inhaled triple therapy,
consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting β 2 …

Inhaled corticosteroids in COPD: friend or foe?

A Agusti, LM Fabbri, D Singh, J Vestbo… - European …, 2018 - Eur Respiratory Soc
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Susceptibility to exacerbation in COPD

JR Hurst, A Anzueto, J Vestbo - The Lancet Respiratory Medicine, 2017 - thelancet.com
We welcome the report by the SPIROMICS investigators in The Lancet Respiratory
Medicine, 1 repeating our 2010 ECLIPSE analysis2 describing exacerbations in chronic …

Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind …

KR Chapman, JR Hurst, SM Frent, M Larbig… - American journal of …, 2018 - atsjournals.org
Rationale: There are no studies on withdrawal of inhaled corticosteroids in patients on long-
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …

[HTML][HTML] Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

JR Hurst, MLK Han, B Singh, S Sharma, G Kaur… - Respiratory …, 2022 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity
and mortality worldwide. COPD exacerbations are associated with a worsening of lung …

Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency

MC Peters, D Mauger, KR Ross, B Phillips… - American journal of …, 2020 - atsjournals.org
Rationale: Cross-sectional studies suggest an exacerbation-prone asthma (EPA) phenotype
and the utility of blood eosinophils and plasma IL-6 as predictive biomarkers. Objectives: To …

Natural history of chronic obstructive pulmonary disease exacerbations in a general practice–based population with chronic obstructive pulmonary disease

KJ Rothnie, H Müllerová, L Smeeth… - American journal of …, 2018 - atsjournals.org
Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are
important adverse events in the natural history of chronic obstructive pulmonary disease …

[HTML][HTML] Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life

JR Hurst, N Skolnik, GJ Hansen, A Anzueto… - European journal of …, 2020 - Elsevier
Exacerbations of chronic obstructive pulmonary disease (COPD) represent a significant
clinical problem, and are associated with decreased lung function, worsening quality of life …